PMC:7536954 / 316-520 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":101,"end":106},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"ics, retinoids, and immunosuppressants/immunomodulants including adalimumab, the first‐approved anti‐tumor necrosis factor‐alpha (TNF)‐α agent. Nevertheless, the presence of autoimmune conditions, particu"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":101,"end":128},"obj":"http://purl.obolibrary.org/obo/PR_000000134"},{"id":"T8","span":{"begin":130,"end":133},"obj":"http://purl.obolibrary.org/obo/PR_000000134"}],"text":"ics, retinoids, and immunosuppressants/immunomodulants including adalimumab, the first‐approved anti‐tumor necrosis factor‐alpha (TNF)‐α agent. Nevertheless, the presence of autoimmune conditions, particu"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":5,"end":14},"obj":"Chemical"},{"id":"T4","span":{"begin":123,"end":128},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_26537"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"}],"text":"ics, retinoids, and immunosuppressants/immunomodulants including adalimumab, the first‐approved anti‐tumor necrosis factor‐alpha (TNF)‐α agent. Nevertheless, the presence of autoimmune conditions, particu"}

{"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":101,"end":128},"obj":"Gene"},{"id":"30","span":{"begin":129,"end":136},"obj":"Gene"},{"id":"33","span":{"begin":5,"end":14},"obj":"Chemical"},{"id":"34","span":{"begin":65,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Gene:7124"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:7124"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D012176"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D000068879"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ics, retinoids, and immunosuppressants/immunomodulants including adalimumab, the first‐approved anti‐tumor necrosis factor‐alpha (TNF)‐α agent. Nevertheless, the presence of autoimmune conditions, particu"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":101,"end":106},"obj":"Phenotype"},{"id":"T7","span":{"begin":174,"end":195},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"ics, retinoids, and immunosuppressants/immunomodulants including adalimumab, the first‐approved anti‐tumor necrosis factor‐alpha (TNF)‐α agent. Nevertheless, the presence of autoimmune conditions, particu"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":107,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0070265"},{"id":"T2","span":{"begin":107,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0019835"},{"id":"T3","span":{"begin":107,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0008219"},{"id":"T4","span":{"begin":107,"end":115},"obj":"http://purl.obolibrary.org/obo/GO_0001906"}],"text":"ics, retinoids, and immunosuppressants/immunomodulants including adalimumab, the first‐approved anti‐tumor necrosis factor‐alpha (TNF)‐α agent. Nevertheless, the presence of autoimmune conditions, particu"}